Clinical Trial Update: A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing rofecoxib and naproxen in Chinese patients with rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Naproxen (Naproxen)
• Vioxx (rofecoxib)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED